Lupin informs about press release

16 Jul 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2361.30 20.55 (0.88%)
11-Mar-2026 14:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.85
Dr. Reddys Lab 1324.50
Cipla 1333.65
Zydus Lifesciences 927.00
Lupin 2361.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×